RECRUITING

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

Talk to us

Conditions

Hypertensionself-monitoringsocial determinants of healthadherence

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.

Official Title

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

Quick Facts

Study Start:2025-02-10
Study Completion:2026-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06899750

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults 18 years or older
  2. * African American and/or Latinx
  3. * Uncontrolled stage 2 hypertension, BP \>/= 140/90
  4. * Patient is following with Rush primary care provider in eligible Rush primary care clinics
  5. * Patient has a smart phone (Android or iOS)
  6. * Patient has an email
  1. * Organ transplant recipient
  2. * On dialysis
  3. * Patient is already participating in another remote hypertension monitoring program
  4. * Patient is not interested in participating in the program
  5. * Patient has already participated in the E3 Hypertension program or the E3 Diabetes program

Contacts and Locations

Study Contact

Kristen Pallok, MD
CONTACT
13129426700
Kristen_N_Pallok@rush.edu
Elizabeth Legorreta, MSN, NP-C
CONTACT
3129426700
Elizabeth_M_Legorreta@rush.edu

Principal Investigator

Kristen Pallok, MD
PRINCIPAL_INVESTIGATOR
Rush University Medical Center

Study Locations (Sites)

Rush University Medical Center
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: Rush University Medical Center

  • Kristen Pallok, MD, PRINCIPAL_INVESTIGATOR, Rush University Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-10
Study Completion Date2026-03-01

Study Record Updates

Study Start Date2025-02-10
Study Completion Date2026-03-01

Terms related to this study

Keywords Provided by Researchers

  • hypertension
  • self-monitoring
  • social determinants of health
  • adherence

Additional Relevant MeSH Terms

  • Hypertension